Background: Quantifying the myocardial blood flow (MBF) using 13 N-ammonia or 15 O-H2O position emission
T he quantitative assessment of coronary flow reserve (CFR) may be useful for the functional evaluation of coronary artery disease (CAD). Positron emission tomography (PET) imaging is considered as the gold standard method to measure the myocardial blood flow (MBF) and CFR in a noninvasive way (1, 2) . The main advantages of MBF and CFR measurements are the unmasking of "balanced ischemia" and the identification of subclinical CAD. In this regard, many reports have suggested that CFR can be a powerful independent predictor of cardiac events and mortality (3) (4) (5) .
However, the use of 15 O-H2O and 13 N-ammonia requires an inhouse cyclotron, and cyclotron is not equipped in many health care centers. Some studies have reported the possibilities of CFR measurements using first-pass planar scintigraphy in humans (6) (7) (8) (9) . On the contrary, recent reports have established the measurement of the MBF and myocardial flow reserve (MFR) using novel cadmium zinc-telluride (CZT) SPECT scanners (10) (11) (12) They also suggested the stable measurements using the effective half-life correction and ordered subset expectation maximization (OSEM). They evaluated the MFR in 29 normal subjects and only one patient with 3 vessel CAD, one with chronic heart failure. They did not examined in patients who have history of CAD or various coronary risk factors.
Therefore, it is not clear whether this MUR approach has clinical utility.
The aim of this study was to evaluate the diagnostic utility of MFR measurement using the new MUR method with 99m Tc-MIBI SPECT studies.
Methods

Study population
We retrospectively included 46 patients who underwent adenosine stress dynamic planar acquisition following conventional SPECT imaging between December 2015 and March 2017 at our hospital (27 males, 19 females; 78.0±6.9 years old). Twenty patients had diabetes mellitus (DM), and 18 patients had chronic kidney disease (CKD) with estimated glomerular filtration rate (eGFR) <45 ml/min, 29 patients had dyslipidemia (Table 1a) . CAD group (n=25) was defined as patients who had significant coronary stenosis (>70%) (14) based on coronary angiography (CAG) or CT angiography 
Tc-MIBI imaging protocol
All patients underwent 1-day adenosine stress and rest imaging protocol. Adenosine was infused at a rate of 0. 14 mg/kg/min for 5 min (15) . Three minutes after the start of adenosine infusion, Tc-MIBI (FUJIFILM RI Pharma Co., Ltd., Tokyo, Japan) (330 MBq) was injected intravenously as a bolus followed by flushing with 20 ml saline. Dynamic images were acquired for 2 min at a rate of 1 frame per second using the anterior planar view (13) . A standard gated-SPECT scan was started 40-60 min after dynamic image acquisition.
The planar dynamic images were used to estimate dynamic counts of blood pool activities, whereas SPECT images were used to estimate myocardial counts. In terms of rest dynamic acquisition, 99m Tc-MIBI (660 MBq) was infused after 1 min pre-scan to obtain a baseline image of the aorta and used to subtract the residual stress counts from the aorta TAC. Predynamic image was acquired for 20 sec before rest dynamic image acquisition, which was used to calculate the effective half-life for decay correction. The complete imaging protocol is shown in Fig. 1a .
SPECT imaging was performed with a dual-head gamma camera (e. cam Signature; Toshiba, Tokyo, Japan) with a low/medium-energy general-purpose collimator. The projec- 
Tc-MIBI visual assessment
Regional 99m Tc-MIBI uptake was assessed using the 17-segment model and semiquantitative scoring system of defect severity and extent. A commercially available software (Heart Risk View-S in AZE Virtual Place Hayabusa, AZE Co., Tokyo, Japan) was used for the semiquantitative assessment.
MFR estimation
We used cardioBull software ver. 5. 1. 4 and MIBI MPR software (FUJIFILM RI Pharma Co., Ltd., Tokyo, Japan) to estimate the MFR as previously described (13) . Briefly, the polar map was generated from SPECT short-axis images. The myocardial count (Cmc) was obtained from these SPECT images. Region of interest (ROI) was set on the ascending aorta and the area under the curve (AUC) of γ-variate-fitted aorta time-activity curve (TAC) was used as the reference count (Fig. 1b) . MUR was obtained using the formula:
Whereas the Cmc is obtained from the SPECT image, AUC is obtained from the planar image and there is a geometric MUR=Cmc×CCF/AUC×100
The left ventricular ROI was delineated manually on the planar image (Fig. 1b) . The effective half-life was calculated using the left ventricular count of planar images at stress and rest. Myocardial count at rest condition was calculated after subtraction of the residual stress count and effective half-life.
Then, the true polar map of rest MUR was generated. The MFR was calculated as the ratio of rest MUR to stress MUR.
Statistics
All statistical analyses were performed using BellCurve for 
Results
Adenosine stress 99m
Tc-MIBI imaging
All patients completed the adenosine stress study without major side effects. No patient had chest pain or severe chest discomfort during adenosine infusion. With adenosine stress, there were significant increases in heart rates (66.3±10.7 vs.
73. 1 ± 12. 2 bpm, p < 0. 001), and significant decreases in systolic blood pressures (128.4±21.5 vs. 106.3±20.8 mmHg, p<0.001). No significant differences were found in diastolic blood pressures (59.9±10.4 vs. 57.7±12.9 mmHg, p=0.25).
Decrease in systolic blood pressure resulted in significant ratepressure product reduction with adenosine stress (8518±1994 vs. 7752±1888, p<0.01).
Quantitative analysis
The estimated MFR values of patient with or without CAD are summarized in (Table   2b and Fig. 2b ).
Multi vessel disease
The global mean MFR of 1 vessel disease (n=20) to those of 2-3 vessel disease (n=5) in the CAD group was compared. 
1.30±0.25) (data not shown). Two of the 46 patients had no
defect or slight abnormal accumulation in the SPECT image but had low MFR, which who were revealed to have multi vessel disease on CAG later. In Fig. 3 , we showed a case with multi vessel disease (3a, 3b) and a case without coronary stenosis (3c, 3d).
Discussion
Quantifying the MFR will play an important role in the diagnosis of patients with CAD as well as risk stratification for cardiac events and mortality (4, 5) . Balanced multi vessel CAD creates a diagnostic dilemma for the nuclear medicine physician. Transient ischemic dilatation (TID) score (16, 17) , decrease in post-stress LV ejection fraction (18) , and increased post-stress end-systolic and/or end-diastolic volume (17) may help to identify balanced ischemia; however, the utility of these markers is limited. Estimated MBF and MFR values can be additional markers to help the physician in the diagnosis.
Earlier studies suggested the possibility of quantifying the MFR on dynamic planar acquisition following conventional SPECT acquired with conventional SPECT cameras (6, 8, 9) .
Furthermore, several reports showed the feasibility of quantifying the MFR with novel CZT SPECT cameras (10) (11) (12) . Despite the advantage of using CZT cameras for estimating the MFR value, including high sensitivity and high resolution, it is still hard to equip these CZT systems in most clinical hospitals because of its high facility cost. Estimating the MFR with the standard dual-head SPECT cameras and common 99m Tc-tracers would increase the utility of MFR In the present study, we used the new MUR method for estimating the MFR in patients and obtained the acceptable values (6, 19) . Ito et al. reported similar method to estimate MBF and MFR using planar and SPECT imaging based on the microsphere method (8) . They used planar static image for calculating myocardial count and estimated MFR, while we used SPECT short axis view and corrected with the CCF in this new MUR method. They used 2-day rest and stress imaging protocol, however, we underwent 1-day stress and rest protocol which is much more common and clinically available. In addition, this new MUR method used effective half-life for decay correction, which was more stable than using physical half-life as previously described (13) . The MFR in patients with known CAD and suspected CAD was lower than that in patients without CAD. We also examined the regional MFR in 5 segments of CAD patients and analyzed the correlation between the MFR and SPECT abnormalities, however, there was no correlation. We compared the global mean MFR of 1 vessel disease to those of 2-3 vessel disease patients. The MFR of 1 vessel disease patients was significantly higher than that of multi vessel disease, which was compatible with earlier studies (12, 20) . In this study, 10 of the CAD group (n=25) had a history of CABG, and 5 of the CAD group had a history of myocardial infarction with fixed perfusion defects in the SPECT, which may affect significantly to the MFR values and complicated the results.
In our study, 2 of the 46 patients were revealed to have significant multi vessel disease after the SPECT study. They Various coronary risk factors, such as CKD, DM, dyslipidemia and current smoking are known to reduce the MFR due to microvascular dysfunction (21, 22) . We also analyzed the MFR in patients with CKD, DM, and dyslipidemia in non-CAD group, which was tended to lower than that of patients who did not have neither risk factors nor CAD (data not shown). We did not examine normal healthy subject in this study, thus we could not confirm relevance of these risk factors and the MFR reduction. Earlier study showed the significant difference between the MFR of diabetic CAD patients and that of non-diabetics using a hybrid SPECT/CT camera (23) . Moreover, they showed the association between age, sex, smoking habit, and reduced MBF.
Therefore, we strongly suggest an importance of MFR estimation to reveal the extent of CAD, detect microvascular disease and improve patient risk stratification.
The limitations in this study is that 99m Tc-tracers have limited extraction fraction at high flow rates, which results in to that with PET or Doppler flowire (7, 8) . Second, we categorized clinical non-CAD group which include 9 non-CAD patients proved by CAG or CTA and 12 patients diagnosed only by the normal SPECT. In this 12 patients, balanced ischemia might have been involved and there is a risk of contamination. Additionally, the interval between CAG or CTA and SPECT study in 9 non-CAD patients was up to 2 years, so that a new stenotic lesion might have progressed during this 2 years. Since there is another risk of contamination in this 9 non-CAD patients. Third, we did not correct the baseline flow values for the rate-pressure product, thus our data was highly variable compared to other studies (8, 9) . Forth, we need to acquire the image for 4 times in this protocol, which may interfere throughput of the test. Therefore, it is hard to apply this method routinely in most of the patients. We suggest this dynamic planar acquisition following conventional SPECT imaging for the patients who have severe LV dysfunction without previous CAD, diffuse hypokinesis with multiple risk factors.
Further studies, on a larger patient cohort, using this MUR analysis method would still be needed. We strongly believe that the estimation of the MFR is a powerful tool and is helpful in the improvement of diagnosis.
Conclusions
The MFR can be accurately estimated with the broadly available SPECT technologies, and the new MUR method is useful for distinguish between CAD and non-CAD patients.
This MUR method will contribute to the widespread use of quantitative MFR in the clinical setting.
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